PRIMIDONE

PRIMIDONE was reported 10263 times

PRIMIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GROWTH HORMONE-PRODUCING PITUITARY TUMOUR 15 0.4688
1 UMBILICAL HAEMORRHAGE 9 0.0596
2 SHUNT MALFUNCTION 15 0.0530
3 PARKINSONIAN REST TREMOR 10 0.0529
4 ESSENTIAL TREMOR 58 0.0520
5 GASTRIC HYPOMOTILITY 15 0.0489
6 LENNOX-GASTAUT SYNDROME 11 0.0485
7 VIRAL DIARRHOEA 15 0.0436
8 SHUNT OCCLUSION 15 0.0295
9 POSTURAL TREMOR 8 0.0274
10 BLOOD GROWTH HORMONE INCREASED 15 0.0269
11 MULTIPLE SYSTEM ATROPHY 8 0.0227
12 CEREBELLAR ATROPHY 20 0.0227
13 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 14 0.0215
14 ANTICONVULSANT DRUG LEVEL INCREASED 28 0.0173
15 ANTICONVULSANT DRUG LEVEL DECREASED 22 0.0156
16 MYOCLONIC EPILEPSY 22 0.0145
17 INGROWN HAIR 10 0.0145
18 INTENTION TREMOR 8 0.0141
19 PLEOCYTOSIS 8 0.0137
20 FOCAL DYSCOGNITIVE SEIZURES 14 0.0123
21 CHOREOATHETOSIS 8 0.0118
22 GINGIVAL HYPERPLASIA 7 0.0117
23 ALCOHOL WITHDRAWAL SYNDROME 10 0.0115
24 MULTIPLE-DRUG RESISTANCE 33 0.0106
25 PETIT MAL EPILEPSY 54 0.0106
26 DEAFNESS TRANSITORY 9 0.0105
27 INSULIN-LIKE GROWTH FACTOR INCREASED 15 0.0105
28 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 8 0.0104
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
30 HEMIANOPIA 10 0.0101
31 HEAD TITUBATION 13 0.0094
32 DRUG WITHDRAWAL CONVULSIONS 15 0.0084
33 PENILE SIZE REDUCED 8 0.0084
34 AURA 15 0.0080
35 ATAXIA 95 0.0080
36 LIP HAEMORRHAGE 10 0.0078
37 ASTERIXIS 8 0.0075
38 OBSTRUCTIVE SLEEP APNOEA SYNDROME 10 0.0069
39 STRABISMUS 20 0.0068
40 NYSTAGMUS 34 0.0064
41 HYPERPARATHYROIDISM SECONDARY 16 0.0064
42 INHIBITORY DRUG INTERACTION 10 0.0063
43 BREATH ODOUR 15 0.0061
44 LIP INJURY 8 0.0061
45 AXILLARY PAIN 9 0.0060
46 PATHOLOGICAL GAMBLING 10 0.0060
47 INFREQUENT BOWEL MOVEMENTS 15 0.0060
48 HYPERAMMONAEMIC ENCEPHALOPATHY 10 0.0057
49 RUBBER SENSITIVITY 8 0.0052
50 EYE CONTUSION 11 0.0052
51 GRAND MAL CONVULSION 48 0.0052
52 VERTIGO POSITIONAL 9 0.0051
53 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 21 0.0051
54 STATUS EPILEPTICUS 57 0.0050
55 NEPHROGENIC ANAEMIA 23 0.0050
56 CRYPTOCOCCOSIS 8 0.0049
57 CLUMSINESS 13 0.0048
58 EXCORIATION 12 0.0047
59 APRAXIA 7 0.0047
60 PSYCHOMOTOR RETARDATION 13 0.0046
61 ORAL INTAKE REDUCED 11 0.0045
62 ELECTROENCEPHALOGRAM ABNORMAL 14 0.0044
63 CONVULSION 250 0.0044
64 PSYCHOTIC SYMPTOM 9 0.0044
65 IMPAIRED SELF-CARE 9 0.0043
66 OBSESSIVE-COMPULSIVE DISORDER 34 0.0042
67 GENERALISED TONIC-CLONIC SEIZURE 69 0.0042
68 OESOPHAGEAL ULCER 16 0.0042
69 NOSOCOMIAL INFECTION 9 0.0041
70 CEREBRAL ATROPHY 16 0.0040
71 DEPRESSIVE SYMPTOM 14 0.0040
72 FEELING DRUNK 29 0.0039
73 AORTIC ARTERIOSCLEROSIS 10 0.0039
74 SPINAL STENOSIS 16 0.0039
75 ESSENTIAL HYPERTENSION 7 0.0038
76 LUMBAR SPINAL STENOSIS 11 0.0038
77 INTERNATIONAL NORMALISED RATIO DECREASED 15 0.0037
78 REBOUND ACID HYPERSECRETION 11 0.0036
79 CLOSTRIDIUM TEST POSITIVE 8 0.0036
80 PARTIAL SEIZURES 19 0.0036
81 PERSECUTORY DELUSION 9 0.0036
82 MASTICATION DISORDER 11 0.0036
83 SEROTONIN SYNDROME 69 0.0036
84 TREMOR 591 0.0036
85 DEVELOPMENTAL DELAY 32 0.0035
86 PARKINSON'S DISEASE 9 0.0035
87 PERIARTHRITIS 8 0.0035
88 DYSGRAPHIA 23 0.0035
89 INFUSION SITE PRURITUS 11 0.0035
90 EAR HAEMORRHAGE 7 0.0035
91 PRE-EXISTING CONDITION IMPROVED 21 0.0034
92 URINARY HESITATION 8 0.0033
93 FACIAL BONES FRACTURE 12 0.0033
94 BODY HEIGHT DECREASED 35 0.0033
95 DIABETIC NEUROPATHY 16 0.0032
96 EYE MOVEMENT DISORDER 22 0.0032
97 EPILEPSY 97 0.0032
98 ANGLE CLOSURE GLAUCOMA 8 0.0031
99 ACTINIC KERATOSIS 8 0.0031
100 CYTOLYTIC HEPATITIS 10 0.0030
101 DIABETIC FOOT 9 0.0029
102 AMMONIA INCREASED 15 0.0029
103 BLOOD BLISTER 9 0.0029
104 COMMUNICATION DISORDER 11 0.0029
105 HYPERREFLEXIA 10 0.0029
106 COORDINATION ABNORMAL 40 0.0029
107 GINGIVAL DISORDER 11 0.0029
108 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
109 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
110 INCOHERENT 18 0.0028
111 SLEEP APNOEA SYNDROME 53 0.0028
112 SUSPECTED SUICIDE 13 0.0028
113 SPINAL OSTEOARTHRITIS 24 0.0027
114 HYPERACUSIS 10 0.0027
115 PSEUDOMONAS INFECTION 23 0.0027
116 WRIST FRACTURE 32 0.0027
117 NORMOCHROMIC NORMOCYTIC ANAEMIA 8 0.0027
118 FOOT DEFORMITY 29 0.0026
119 HYPERAMMONAEMIA 13 0.0026
120 DRUG INTERACTION 410 0.0026
121 DIPLOPIA 67 0.0026
122 CAROTID ARTERY STENOSIS 9 0.0026
123 CLONUS 7 0.0026
124 BALANCE DISORDER 221 0.0026
125 LOGORRHOEA 9 0.0026
126 BRADYKINESIA 15 0.0025
127 HYPERLIPIDAEMIA 30 0.0025
128 DYSPHEMIA 11 0.0025
129 SUBCUTANEOUS ABSCESS 12 0.0025
130 TRIGEMINAL NEURALGIA 10 0.0025
131 MAJOR DEPRESSION 18 0.0025
132 WOUND HAEMORRHAGE 9 0.0024
133 SEIZURE 277 0.0024
134 INFUSION SITE SWELLING 15 0.0024
135 KLEBSIELLA INFECTION 12 0.0024
136 FACE INJURY 9 0.0024
137 CLAVICLE FRACTURE 9 0.0023
138 RIB FRACTURE 48 0.0023
139 HYPERCAPNIA 7 0.0023
140 CERVICAL VERTEBRAL FRACTURE 8 0.0023
141 LYMPHOEDEMA 16 0.0023
142 BIPOLAR DISORDER 25 0.0023
143 BRAIN INJURY 23 0.0023
144 PARKINSONISM 22 0.0023
145 METABOLIC DISORDER 13 0.0022
146 FRUSTRATION TOLERANCE DECREASED 18 0.0022
147 BLEPHAROSPASM 14 0.0022
148 FOOT OPERATION 11 0.0022
149 MULTIPLE DRUG OVERDOSE 11 0.0022
150 DYSARTHRIA 83 0.0022
151 BILE DUCT STONE 7 0.0022
152 CEREBRAL DISORDER 16 0.0022
153 ENCEPHALOPATHY 53 0.0022
154 RESTLESS LEGS SYNDROME 39 0.0021
155 HALLUCINATIONS, MIXED 9 0.0021
156 HEPATIC NECROSIS 8 0.0021
157 PHARMACEUTICAL PRODUCT COMPLAINT 55 0.0021
158 INTERVERTEBRAL DISC DISORDER 9 0.0021
159 FAECAL INCONTINENCE 10 0.0021
160 DRUG LEVEL DECREASED 21 0.0021
161 MENTAL STATUS CHANGES 57 0.0021
162 DIFFICULTY IN WALKING 7 0.0020
163 BLINDNESS TRANSIENT 15 0.0020
164 COMPLETED SUICIDE 169 0.0020
165 FALL 673 0.0020
166 TRICUSPID VALVE INCOMPETENCE 16 0.0020
167 MENINGITIS ASEPTIC 9 0.0020
168 HEAD INJURY 63 0.0020
169 SOMNAMBULISM 13 0.0020
170 GINGIVAL BLEEDING 27 0.0020
171 BACK DISORDER 32 0.0020
172 ATELECTASIS 19 0.0020
173 HAEMORRHAGIC DIATHESIS 7 0.0020
174 HYPERSOMNIA 56 0.0020
175 SOMNOLENCE 392 0.0019
176 ANKLE FRACTURE 30 0.0019
177 SPINAL COMPRESSION FRACTURE 16 0.0019
178 SKIN LACERATION 21 0.0019
179 HIP FRACTURE 62 0.0019
180 TIBIA FRACTURE 9 0.0019
181 CAROTID ARTERY OCCLUSION 7 0.0019
182 BLADDER DISORDER 19 0.0019
183 SKIN ABRASION 9 0.0019
184 JOINT DISLOCATION 20 0.0019
185 LOSS OF LIBIDO 17 0.0019
186 INTERVERTEBRAL DISC PROTRUSION 41 0.0019
187 LOWER LIMB FRACTURE 36 0.0019
188 PURULENT DISCHARGE 8 0.0019
189 HUMERUS FRACTURE 9 0.0019
190 BEHAVIOUR DISORDER 10 0.0018
191 VITAMIN D DEFICIENCY 18 0.0018
192 HALLUCINATION 139 0.0018
193 NERVE COMPRESSION 17 0.0018
194 AORTIC ANEURYSM 14 0.0018
195 HAND FRACTURE 13 0.0018
196 HYPERTHERMIA 14 0.0018
197 WALKING AID USER 12 0.0018
198 INGUINAL HERNIA 11 0.0018
199 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
200 UPPER LIMB FRACTURE 36 0.0018
201 HALLUCINATION, VISUAL 38 0.0018
202 PELVIC FRACTURE 14 0.0018
203 MUSCLE SPASTICITY 22 0.0018
204 SPINAL OPERATION 22 0.0018
205 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
206 ECONOMIC PROBLEM 27 0.0018
207 OSTEOPENIA 27 0.0018
208 SCOLIOSIS 11 0.0018
209 VASCULAR DEVICE INFECTION 8 0.0018
210 ATRIAL FLUTTER 14 0.0018
211 BEDRIDDEN 23 0.0017
212 CEREBRAL ISCHAEMIA 9 0.0017
213 PULMONARY CONGESTION 23 0.0017
214 MYOPATHY 15 0.0017
215 HERPES VIRUS INFECTION 10 0.0017
216 IRON DEFICIENCY ANAEMIA 16 0.0017
217 ENURESIS 7 0.0017
218 LARGE INTESTINE POLYP 12 0.0017
219 OSTEOPOROSIS 71 0.0017
220 LIGAMENT SPRAIN 17 0.0017
221 DECUBITUS ULCER 14 0.0017
222 SPINAL COLUMN STENOSIS 8 0.0017
223 DRUG TOXICITY 23 0.0017
224 BRADYPHRENIA 11 0.0017
225 CONCUSSION 13 0.0017
226 DYSKINESIA 68 0.0017
227 STRESS FRACTURE 9 0.0017
228 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
229 VISUAL FIELD DEFECT 12 0.0017
230 ABASIA 41 0.0017
231 HELICOBACTER INFECTION 17 0.0017
232 MULTIPLE SCLEROSIS 79 0.0017
233 JAW DISORDER 9 0.0016
234 NONSPECIFIC REACTION 9 0.0016
235 FOOT FRACTURE 31 0.0016
236 IMPAIRED GASTRIC EMPTYING 22 0.0016
237 DEMENTIA 45 0.0016
238 DELUSION 25 0.0016
239 MITRAL VALVE INCOMPETENCE 18 0.0016
240 COGNITIVE DISORDER 74 0.0016
241 PRODUCT SOLUBILITY ABNORMAL 8 0.0016
242 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 14 0.0016
243 MICTURITION URGENCY 18 0.0016
244 MOTOR DYSFUNCTION 16 0.0016
245 AMNESIA 102 0.0016
246 NOCTURIA 19 0.0016
247 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
248 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
249 SMALL INTESTINAL OBSTRUCTION 19 0.0015
250 GAIT DISTURBANCE 295 0.0015
251 CHRONIC KIDNEY DISEASE 117 0.0015
252 BLOOD SODIUM DECREASED 29 0.0015
253 HEMIPARESIS 26 0.0015
254 ABDOMINAL HERNIA 7 0.0015
255 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
256 HOSPICE CARE 15 0.0015
257 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 79 0.0015
258 GASTRITIS EROSIVE 7 0.0015
259 FLANK PAIN 14 0.0015
260 COMPRESSION FRACTURE 8 0.0015
261 PSYCHIATRIC SYMPTOM 11 0.0015
262 LACERATION 14 0.0015
263 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
264 MYASTHENIA GRAVIS 12 0.0015
265 TENSION 9 0.0015
266 DYSSTASIA 43 0.0015
267 LUNG INFILTRATION 13 0.0015
268 HIATUS HERNIA 19 0.0015
269 SINUS DISORDER 29 0.0015
270 OSTEOARTHRITIS 62 0.0015
271 TENDON RUPTURE 18 0.0015
272 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 80 0.0015
273 JOINT INJURY 31 0.0014
274 PARANOIA 25 0.0014
275 ENCEPHALITIS 10 0.0014
276 ORTHOSTATIC HYPOTENSION 25 0.0014
277 NEUROLEPTIC MALIGNANT SYNDROME 17 0.0014
278 MYOCLONUS 17 0.0014
279 HEART RATE DECREASED 50 0.0014
280 EYE HAEMORRHAGE 19 0.0014
281 MACULAR DEGENERATION 17 0.0014
282 INFUSION SITE ERYTHEMA 12 0.0014
283 URINARY INCONTINENCE 42 0.0014
284 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
285 UROSEPSIS 13 0.0014
286 HAEMORRHAGIC STROKE 11 0.0014
287 PULMONARY HAEMORRHAGE 11 0.0014
288 HYPERNATRAEMIA 7 0.0014
289 PERSONALITY CHANGE 13 0.0014
290 SUBDURAL HAEMATOMA 20 0.0014
291 ERUCTATION 27 0.0014
292 SKIN ATROPHY 8 0.0014
293 MEMORY IMPAIRMENT 190 0.0014
294 CARDIOMEGALY 17 0.0014
295 CYSTITIS 44 0.0014
296 ARTERIOSCLEROSIS 13 0.0014
297 SPINAL DISORDER 13 0.0014
298 CONTUSION 132 0.0014
299 SENSORY LOSS 11 0.0014
300 FEMORAL NECK FRACTURE 7 0.0014
301 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
302 LOCALISED INFECTION 33 0.0014
303 CACHEXIA 7 0.0014
304 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
305 SPEECH DISORDER 71 0.0014
306 SPINAL FRACTURE 27 0.0013
307 PLEURISY 8 0.0013
308 SEASONAL ALLERGY 19 0.0013
309 MIDDLE INSOMNIA 25 0.0013
310 ANAL INCONTINENCE 12 0.0013
311 STAPHYLOCOCCAL INFECTION 44 0.0013
312 KNEE ARTHROPLASTY 28 0.0013
313 ROTATOR CUFF SYNDROME 17 0.0013
314 OEDEMA PERIPHERAL 161 0.0013
315 OPTIC NEURITIS 12 0.0013
316 CORONARY ARTERY OCCLUSION 18 0.0013
317 LOSS OF CONSCIOUSNESS 168 0.0013
318 SKIN CANCER 28 0.0013
319 HYPOKALAEMIA 60 0.0013
320 DECREASED ACTIVITY 14 0.0013
321 THYROID DISORDER 20 0.0013
322 HIP SURGERY 7 0.0013
323 CONFUSIONAL STATE 209 0.0013
324 GASTRITIS 34 0.0013
325 LIMB INJURY 35 0.0013
326 THINKING ABNORMAL 24 0.0013
327 VITAMIN D DECREASED 11 0.0013
328 DEFAECATION URGENCY 9 0.0013
329 ASPIRATION 14 0.0013
330 HYPONATRAEMIA 72 0.0013
331 URINARY TRACT INFECTION 218 0.0013
332 SQUAMOUS CELL CARCINOMA 12 0.0013
333 MULTIPLE INJURIES 8 0.0013
334 CHOKING SENSATION 7 0.0013
335 DRUG LEVEL INCREASED 21 0.0013
336 MUSCULOSKELETAL DISORDER 24 0.0013
337 TEMPERATURE INTOLERANCE 13 0.0013
338 NERVE INJURY 14 0.0013
339 HALLUCINATION, AUDITORY 20 0.0013
340 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
341 BLOOD COUNT ABNORMAL 19 0.0013
342 HYPOTHYROIDISM 40 0.0013
343 TENDERNESS 13 0.0012
344 PANIC REACTION 9 0.0012
345 MOVEMENT DISORDER 40 0.0012
346 CANDIDA INFECTION 21 0.0012
347 APATHY 18 0.0012
348 FACIAL PAIN 11 0.0012
349 IMPAIRED DRIVING ABILITY 14 0.0012
350 INCONTINENCE 13 0.0012
351 POST PROCEDURAL INFECTION 10 0.0012
352 RENAL TUBULAR NECROSIS 12 0.0012
353 POLYP 8 0.0012
354 NEPHROLITHIASIS 56 0.0012
355 OROPHARYNGEAL DISCOMFORT 11 0.0012
356 LETHARGY 70 0.0012
357 BLOOD URIC ACID INCREASED 7 0.0012
358 WEIGHT DECREASED 338 0.0012
359 DRUG RESISTANCE 31 0.0012
360 END STAGE RENAL DISEASE 22 0.0012
361 EXOSTOSIS 11 0.0012
362 PNEUMOTHORAX 19 0.0012
363 BLOOD POTASSIUM DECREASED 36 0.0012
364 INCREASED TENDENCY TO BRUISE 11 0.0012
365 OBESITY 19 0.0012
366 BREAST MASS 8 0.0012
367 BRAIN OEDEMA 15 0.0012
368 DECREASED INTEREST 7 0.0012
369 TRANSIENT ISCHAEMIC ATTACK 40 0.0012
370 PSYCHOTIC DISORDER 35 0.0012
371 EYELID PTOSIS 12 0.0012
372 TOOTH FRACTURE 13 0.0012
373 HAEMORRHOIDS 23 0.0012
374 MUSCULAR WEAKNESS 134 0.0012
375 INSURANCE ISSUE 18 0.0012
376 DENTAL CARIES 13 0.0012
377 CARDIAC PACEMAKER INSERTION 7 0.0012
378 MATERNAL DRUGS AFFECTING FOETUS 9 0.0012
379 ROAD TRAFFIC ACCIDENT 49 0.0012
380 MUSCLE RIGIDITY 14 0.0012
381 DYSPHAGIA 111 0.0012
382 RENAL FAILURE 155 0.0012
383 PNEUMONIA ASPIRATION 29 0.0012
384 BLOOD MAGNESIUM DECREASED 10 0.0012
385 CATARACT 69 0.0012
386 APNOEA 9 0.0012
387 MUSCLE STRAIN 10 0.0012
388 DIVERTICULITIS 32 0.0012
389 URINE OUTPUT DECREASED 10 0.0011
390 DRUG SCREEN POSITIVE 9 0.0011
391 BRONCHITIS 84 0.0011
392 ULCER 18 0.0011
393 MUSCLE TWITCHING 26 0.0011
394 EATING DISORDER 24 0.0011
395 RESPIRATORY RATE INCREASED 10 0.0011
396 HEPATOTOXICITY 25 0.0011
397 GALLBLADDER DISORDER 20 0.0011
398 POISONING 14 0.0011
399 DYSURIA 41 0.0011
400 ABNORMAL BEHAVIOUR 44 0.0011
401 NEURALGIA 27 0.0011
402 HAEMATOCRIT DECREASED 22 0.0011
403 CARDIAC FAILURE CONGESTIVE 89 0.0011
404 GASTROENTERITIS VIRAL 20 0.0011
405 NEUROPATHY PERIPHERAL 105 0.0011
406 BACK INJURY 12 0.0011
407 HYPOKINESIA 16 0.0011
408 SALIVARY HYPERSECRETION 11 0.0011
409 AGGRESSION 55 0.0011
410 MUSCULOSKELETAL CHEST PAIN 17 0.0011
411 FEMUR FRACTURE 34 0.0011
412 BLOOD IRON DECREASED 13 0.0011
413 DELIRIUM 38 0.0011
414 ANGER 37 0.0011
415 CHOLESTASIS 21 0.0011
416 ACUTE RESPIRATORY FAILURE 21 0.0011
417 NECK PAIN 61 0.0011
418 EMPHYSEMA 11 0.0011
419 AGITATION 80 0.0011
420 DYSPNOEA EXERTIONAL 41 0.0011
421 INFUSION SITE PAIN 14 0.0011
422 ANOREXIA 14 0.0011
423 OXYGEN SATURATION DECREASED 61 0.0011
424 DISORIENTATION 43 0.0011
425 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
426 VISUAL ACUITY REDUCED 36 0.0011
427 APHONIA 15 0.0011
428 IRRITABLE BOWEL SYNDROME 23 0.0011
429 INITIAL INSOMNIA 11 0.0011
430 BURSITIS 13 0.0011
431 CARPAL TUNNEL SYNDROME 15 0.0011
432 SEDATION 28 0.0011
433 BLOOD CALCIUM DECREASED 12 0.0011
434 LIMB DISCOMFORT 33 0.0011
435 IMMUNE SYSTEM DISORDER 14 0.0011
436 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
437 DYSPHONIA 62 0.0011
438 CONSTIPATION 231 0.0011
439 MOBILITY DECREASED 76 0.0011
440 ERECTILE DYSFUNCTION 27 0.0011
441 WEIGHT FLUCTUATION 11 0.0011
442 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
443 POST PROCEDURAL COMPLICATION 20 0.0010
444 BRONCHIECTASIS 7 0.0010
445 TOXICITY TO VARIOUS AGENTS 175 0.0010
446 HERNIA 20 0.0010
447 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
448 MANIA 17 0.0010
449 ARTHRITIS 81 0.0010
450 EYE PAIN 58 0.0010
451 GROIN PAIN 9 0.0010
452 DIZZINESS 508 0.0010
453 GAIT INABILITY 34 0.0010
454 RESPIRATORY ARREST 28 0.0010
455 PULMONARY THROMBOSIS 11 0.0010
456 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
457 ARTHROPATHY 56 0.0010
458 POLLAKIURIA 42 0.0010
459 WOUND INFECTION 11 0.0010
460 FRACTURE 19 0.0010
461 DEPRESSION 228 0.0010
462 NEEDLE ISSUE 29 0.0010
463 ATRIAL FIBRILLATION 97 0.0010
464 PNEUMONIA 322 0.0010
465 APHASIA 30 0.0010
466 TARDIVE DYSKINESIA 28 0.0010
467 GASTRIC DISORDER 34 0.0010
468 URINARY RETENTION 33 0.0010
469 MUSCLE TIGHTNESS 16 0.0010
470 FLATULENCE 56 0.0010
471 FIBROMYALGIA 24 0.0010
472 VERTIGO 60 0.0010
473 BLOOD PRESSURE INCREASED 150 0.0010
474 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
475 ASTHENIA 365 0.0010
476 PARAESTHESIA ORAL 14 0.0010
477 HAEMATOMA 25 0.0010
478 DERMATITIS CONTACT 11 0.0010
479 PSYCHOMOTOR HYPERACTIVITY 16 0.0010
480 MIGRAINE 92 0.0010
481 CHOLECYSTECTOMY 11 0.0010
482 COAGULOPATHY 16 0.0010
483 GASTROENTERITIS 14 0.0010
484 SECRETION DISCHARGE 12 0.0010
485 GASTROOESOPHAGEAL REFLUX DISEASE 77 0.0010
486 BACK PAIN 222 0.0010
487 HAEMODIALYSIS 8 0.0010
488 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
489 SINUSITIS 97 0.0009
490 STEVENS-JOHNSON SYNDROME 21 0.0009
491 MENTAL DISORDER 41 0.0009
492 CONDITION AGGRAVATED 286 0.0009
493 PRODUCT ADMINISTRATION ERROR 19 0.0009
494 OSTEOMYELITIS 17 0.0009
495 PULMONARY FIBROSIS 18 0.0009
496 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 45 0.0009
497 THERAPEUTIC RESPONSE UNEXPECTED 42 0.0009
498 CRYING 34 0.0009
499 DEHYDRATION 124 0.0009
500 CARDIAC MURMUR 8 0.0009
501 HYSTERECTOMY 8 0.0009
502 BLINDNESS UNILATERAL 13 0.0009
503 ACCIDENT 11 0.0009
504 THROMBOSIS 74 0.0009
505 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
506 DRUG DISPENSING ERROR 14 0.0009
507 OESOPHAGITIS 10 0.0009
508 PULMONARY HYPERTENSION 19 0.0009
509 COUGH 255 0.0009
510 GRIP STRENGTH DECREASED 8 0.0009
511 INABILITY TO AFFORD MEDICATION 9 0.0009
512 FEELING ABNORMAL 217 0.0009
513 PHOTOPHOBIA 17 0.0009
514 VISION BLURRED 124 0.0009
515 APHTHOUS ULCER 7 0.0009
516 DRY MOUTH 73 0.0009
517 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
518 HEPATIC FAILURE 27 0.0009
519 GASTRIC ULCER 17 0.0009
520 MALNUTRITION 10 0.0009
521 RASH PAPULAR 20 0.0009
522 CORONARY ARTERY DISEASE 27 0.0009
523 INJECTION SITE EXTRAVASATION 11 0.0009
524 OCULAR DISCOMFORT 10 0.0009
525 ARTERIAL OCCLUSIVE DISEASE 7 0.0009
526 AFFECTIVE DISORDER 7 0.0009
527 DISTURBANCE IN ATTENTION 48 0.0009
528 INFLUENZA 99 0.0009
529 EXTRAPYRAMIDAL DISORDER 22 0.0009
530 SLUGGISHNESS 9 0.0009
531 RESPIRATORY TRACT CONGESTION 14 0.0009
532 HYPOXIA 31 0.0009
533 PRESCRIBED OVERDOSE 17 0.0009
534 SCIATICA 14 0.0009
535 BONE DISORDER 16 0.0009
536 SKIN HAEMORRHAGE 13 0.0009
537 INTERNAL HAEMORRHAGE 10 0.0009
538 ACCIDENTAL OVERDOSE 32 0.0009
539 PERIPHERAL COLDNESS 12 0.0009
540 SENSORY DISTURBANCE 14 0.0009
541 BONE PAIN 51 0.0009
542 SKIN FISSURES 17 0.0009
543 ABNORMAL DREAMS 24 0.0009
544 KIDNEY INFECTION 17 0.0009
545 ORAL DISCOMFORT 12 0.0009
546 BLOOD POTASSIUM INCREASED 14 0.0009
547 BLINDNESS 35 0.0009
548 PRODUCT USE ISSUE 161 0.0009
549 DRUG EFFECT DECREASED 46 0.0009
550 DIABETES MELLITUS 65 0.0009
551 SLEEP DISORDER 60 0.0008
552 PULMONARY OEDEMA 38 0.0008
553 HEAD DISCOMFORT 15 0.0008
554 PHARYNGEAL OEDEMA 13 0.0008
555 BLOOD PRESSURE DECREASED 56 0.0008
556 NERVOUSNESS 44 0.0008
557 INTERNATIONAL NORMALISED RATIO INCREASED 24 0.0008
558 DRY EYE 42 0.0008
559 HEART RATE IRREGULAR 19 0.0008
560 COMA 40 0.0008
561 PARALYSIS 12 0.0008
562 CEREBRAL HAEMORRHAGE 30 0.0008
563 PRODUCTIVE COUGH 40 0.0008
564 BLOOD CHOLESTEROL INCREASED 39 0.0008
565 POOR QUALITY SLEEP 18 0.0008
566 POLYNEUROPATHY 10 0.0008
567 FATIGUE 650 0.0008
568 WHITE BLOOD CELL COUNT INCREASED 32 0.0008
569 THERAPY PARTIAL RESPONDER 13 0.0008
570 BLOOD PRESSURE FLUCTUATION 20 0.0008
571 UNEVALUABLE EVENT 63 0.0008
572 AFFECT LABILITY 8 0.0008
573 GLAUCOMA 16 0.0008
574 EAR INFECTION 22 0.0008
575 PRODUCT USE COMPLAINT 13 0.0008
576 MENTAL IMPAIRMENT 20 0.0008
577 ARRHYTHMIA 39 0.0008
578 SCHIZOPHRENIA 10 0.0008
579 AUTOIMMUNE DISORDER 8 0.0008
580 CHOKING 16 0.0008
581 THERAPY CESSATION 42 0.0008
582 INSOMNIA 217 0.0008
583 HEPATOMEGALY 8 0.0008
584 CARDIAC DISORDER 76 0.0008
585 TOOTH DISORDER 18 0.0008
586 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
587 PHARYNGITIS 10 0.0008
588 HEPATIC STEATOSIS 15 0.0008
589 WEIGHT INCREASED 180 0.0008
590 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0008
591 TOOTH EXTRACTION 10 0.0008
592 TYPE 2 DIABETES MELLITUS 27 0.0008
593 HYPOAESTHESIA 120 0.0008
594 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
595 OVARIAN CYST 8 0.0008
596 PRODUCT SUBSTITUTION ISSUE 46 0.0008
597 VISUAL IMPAIRMENT 99 0.0008
598 BURNING SENSATION 56 0.0008
599 BLOOD CALCIUM INCREASED 7 0.0008
600 RESPIRATORY DISTRESS 22 0.0008
601 DEPRESSED MOOD 42 0.0008
602 FULL BLOOD COUNT DECREASED 16 0.0008
603 CELLULITIS 40 0.0008
604 HYPERTENSION 168 0.0008
605 PROCEDURAL PAIN 22 0.0008
606 RESTLESSNESS 29 0.0008
607 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
608 BRADYCARDIA 42 0.0008
609 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
610 MUSCLE ATROPHY 10 0.0008
611 HAEMATURIA 27 0.0008
612 MASS 11 0.0008
613 WOUND 22 0.0008
614 FLUID RETENTION 40 0.0008
615 TOOTH ABSCESS 8 0.0008
616 DIARRHOEA 506 0.0008
617 BLOOD TEST ABNORMAL 11 0.0008
618 IRRITABILITY 47 0.0008
619 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
620 EUPHORIC MOOD 8 0.0008
621 PRODUCT DISPENSING ERROR 17 0.0008
622 NIGHTMARE 27 0.0008
623 HEPATIC ENZYME INCREASED 53 0.0008
624 LUNG INFECTION 12 0.0008
625 EAR PAIN 15 0.0008
626 EYE DISCHARGE 8 0.0008
627 SPLENOMEGALY 9 0.0008
628 CARDIOGENIC SHOCK 11 0.0008
629 INTENTIONAL PRODUCT USE ISSUE 67 0.0008
630 CHOLELITHIASIS 25 0.0008
631 ASTHMA 86 0.0008
632 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
633 FULL BLOOD COUNT ABNORMAL 8 0.0008
634 THERAPY INTERRUPTED 54 0.0008
635 MUSCULOSKELETAL DISCOMFORT 13 0.0008
636 MOOD SWINGS 24 0.0008
637 TREATMENT NONCOMPLIANCE 41 0.0007
638 PRODUCT AVAILABILITY ISSUE 17 0.0007
639 MUSCLE SPASMS 137 0.0007
640 EMOTIONAL DISORDER 23 0.0007
641 LOCAL SWELLING 13 0.0007
642 CHEST PAIN 138 0.0007
643 FEAR 20 0.0007
644 HYPOACUSIS 32 0.0007
645 INTESTINAL OBSTRUCTION 28 0.0007
646 CARDIO-RESPIRATORY ARREST 31 0.0007
647 PRURITUS GENERALISED 16 0.0007
648 SYNCOPE 74 0.0007
649 PHARYNGITIS STREPTOCOCCAL 8 0.0007
650 PULMONARY MASS 11 0.0007
651 HYPOTENSION 148 0.0007
652 NERVOUS SYSTEM DISORDER 23 0.0007
653 UNRESPONSIVE TO STIMULI 19 0.0007
654 RED BLOOD CELL COUNT DECREASED 21 0.0007
655 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
656 INTENTIONAL PRODUCT MISUSE 64 0.0007
657 IMPAIRED HEALING 24 0.0007
658 RENAL FAILURE ACUTE 31 0.0007
659 HYPERCALCAEMIA 9 0.0007
660 RHINORRHOEA 47 0.0007
661 PAIN IN EXTREMITY 214 0.0007
662 ANXIETY 206 0.0007
663 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
664 ILLNESS 74 0.0007
665 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
666 GASTROINTESTINAL DISORDER 64 0.0007
667 SNEEZING 16 0.0007
668 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
669 INJURY 50 0.0007
670 ABDOMINAL DISTENSION 74 0.0007
671 CHROMATURIA 16 0.0007
672 CEREBROVASCULAR ACCIDENT 120 0.0007
673 RENAL INJURY 21 0.0007
674 SWELLING FACE 46 0.0007
675 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
676 GASTROINTESTINAL HAEMORRHAGE 59 0.0007
677 BASAL CELL CARCINOMA 11 0.0007
678 PULMONARY EMBOLISM 67 0.0007
679 BLOOD PRESSURE ABNORMAL 14 0.0007
680 RETCHING 15 0.0007
681 CYANOSIS 11 0.0007
682 SKIN ULCER 18 0.0007
683 NEOPLASM 8 0.0007
684 GASTRIC HAEMORRHAGE 8 0.0007
685 PERIPHERAL SWELLING 107 0.0007
686 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
687 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
688 HYPOTHERMIA 7 0.0007
689 WHEEZING 41 0.0007
690 THERAPY NON-RESPONDER 31 0.0007
691 FLUID OVERLOAD 10 0.0007
692 RENAL DISORDER 32 0.0007
693 COLITIS 26 0.0007
694 BLOOD URINE PRESENT 13 0.0007
695 DRUG ADMINISTRATION ERROR 21 0.0007
696 ABDOMINAL PAIN 159 0.0007
697 SUICIDAL IDEATION 62 0.0007
698 TREATMENT FAILURE 56 0.0007
699 RECTAL HAEMORRHAGE 29 0.0007
700 ISCHAEMIC STROKE 12 0.0007
701 MALIGNANT MELANOMA 9 0.0007
702 PRURITUS 258 0.0007
703 DYSTONIA 13 0.0007
704 RESPIRATORY DISORDER 20 0.0007
705 MUSCULOSKELETAL PAIN 35 0.0007
706 PANCREATITIS ACUTE 15 0.0007
707 MEDICATION ERROR 37 0.0007
708 HYPOPHAGIA 17 0.0007
709 NEOPLASM PROGRESSION 23 0.0007
710 NO THERAPEUTIC RESPONSE 8 0.0007
711 DEAFNESS 17 0.0006
712 DYSPNOEA 368 0.0006
713 FLUSHING 66 0.0006
714 HEADACHE 407 0.0006
715 SURGERY 38 0.0006
716 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
717 DEEP VEIN THROMBOSIS 42 0.0006
718 DECREASED APPETITE 150 0.0006
719 FAECES DISCOLOURED 14 0.0006
720 HYPERHIDROSIS 83 0.0006
721 EJECTION FRACTION DECREASED 10 0.0006
722 EYE IRRITATION 37 0.0006
723 DRUG INEFFECTIVE 845 0.0006
724 SWOLLEN TONGUE 20 0.0006
725 HYPOGLYCAEMIA 31 0.0006
726 HEPATIC CIRRHOSIS 12 0.0006
727 BRAIN FOG 10 0.0006
728 SEPSIS 71 0.0006
729 FEELING HOT 39 0.0006
730 DIALYSIS 9 0.0006
731 PRODUCT USE IN UNAPPROVED INDICATION 157 0.0006
732 C-REACTIVE PROTEIN INCREASED 23 0.0006
733 FUNGAL INFECTION 21 0.0006
734 INCREASED APPETITE 12 0.0006
735 MUSCULOSKELETAL STIFFNESS 55 0.0006
736 INTRAOCULAR PRESSURE INCREASED 8 0.0006
737 PRODUCT DOSE OMISSION ISSUE 184 0.0006
738 BLOOD GLUCOSE DECREASED 30 0.0006
739 THROAT IRRITATION 28 0.0006
740 ANAEMIA 119 0.0006
741 MOOD ALTERED 17 0.0006
742 DRUG INTOLERANCE 60 0.0006
743 SEPTIC SHOCK 27 0.0006
744 EYE SWELLING 23 0.0006
745 RESPIRATORY FAILURE 45 0.0006
746 EPISTAXIS 46 0.0006
747 LUNG DISORDER 30 0.0006
748 LIVER INJURY 15 0.0006
749 MALAISE 268 0.0006
750 FEELING COLD 17 0.0006
751 HOT FLUSH 46 0.0006
752 PARAESTHESIA 96 0.0006
753 LABORATORY TEST ABNORMAL 18 0.0006
754 COVID-19 107 0.0006
755 DYSPEPSIA 60 0.0006
756 RASH PRURITIC 33 0.0006
757 IMPAIRED WORK ABILITY 13 0.0006
758 PLEURAL EFFUSION 37 0.0006
759 DYSGEUSIA 45 0.0006
760 NAUSEA 479 0.0006
761 COLON CANCER 9 0.0006
762 PRESCRIBED UNDERDOSE 12 0.0006
763 VIRAL INFECTION 20 0.0006
764 PAIN IN JAW 17 0.0006
765 CHILLS 70 0.0006
766 HEART RATE INCREASED 59 0.0006
767 COVID-19 PNEUMONIA 7 0.0006
768 SINUS CONGESTION 8 0.0006
769 TASTE DISORDER 12 0.0006
770 OEDEMA 32 0.0006
771 BACTERAEMIA 7 0.0006
772 BODY TEMPERATURE INCREASED 12 0.0006
773 ACUTE KIDNEY INJURY 90 0.0006
774 ABDOMINAL PAIN UPPER 120 0.0006
775 LYMPHOMA 9 0.0006
776 OFF LABEL USE 509 0.0006
777 TENDONITIS 9 0.0006
778 PERITONITIS 12 0.0006
779 ADVERSE DRUG REACTION 52 0.0006
780 DRUG EFFECT INCOMPLETE 21 0.0006
781 SWELLING 54 0.0006
782 PANIC ATTACK 21 0.0006
783 CHEST DISCOMFORT 59 0.0006
784 HAEMOPTYSIS 16 0.0006
785 VOMITING 269 0.0006
786 DEVICE USE ISSUE 10 0.0006
787 EXPIRED PRODUCT ADMINISTERED 19 0.0006
788 SKIN DISCOLOURATION 26 0.0006
789 HYPERSENSITIVITY 105 0.0006
790 GENERALISED OEDEMA 7 0.0006
791 LYMPHADENOPATHY 20 0.0006
792 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
793 HAEMORRHAGE 59 0.0006
794 CYST 7 0.0006
795 LACRIMATION INCREASED 17 0.0006
796 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 40 0.0006
797 BRONCHOSPASM 8 0.0006
798 ABDOMINAL DISCOMFORT 94 0.0006
799 GOUT 10 0.0006
800 ALOPECIA 109 0.0006
801 DEVICE MALFUNCTION 39 0.0006
802 ARTHRALGIA 230 0.0006
803 LEUKOCYTOSIS 10 0.0006
804 HAEMATEMESIS 14 0.0006
805 PNEUMONITIS 15 0.0006
806 PANCREATITIS 29 0.0005
807 OCULAR HYPERAEMIA 26 0.0005
808 SKIN LESION 15 0.0005
809 INFECTION 79 0.0005
810 PRODUCT PHYSICAL ISSUE 11 0.0005
811 MELAENA 12 0.0005
812 CARDIAC ARREST 45 0.0005
813 NASAL CONGESTION 32 0.0005
814 HERPES ZOSTER 31 0.0005
815 RASH 235 0.0005
816 CONJUNCTIVITIS 10 0.0005
817 PAIN 331 0.0005
818 RESPIRATORY TRACT INFECTION 14 0.0005
819 UNDERDOSE 39 0.0005
820 BLISTER 30 0.0005
821 BLOOD GLUCOSE INCREASED 100 0.0005
822 INJECTION SITE HAEMORRHAGE 42 0.0005
823 FEELING JITTERY 10 0.0005
824 ANGINA PECTORIS 15 0.0005
825 HAIR TEXTURE ABNORMAL 7 0.0005
826 TINNITUS 24 0.0005
827 MOUTH ULCERATION 11 0.0005
828 OVERDOSE 112 0.0005
829 EYE DISORDER 17 0.0005
830 HAEMOGLOBIN DECREASED 53 0.0005
831 NASOPHARYNGITIS 95 0.0005
832 TACHYCARDIA 45 0.0005
833 EYE PRURITUS 17 0.0005
834 PRODUCT DOSE OMISSION 33 0.0005
835 HYPOMAGNESAEMIA 7 0.0005
836 RASH GENERALISED 13 0.0005
837 ABSCESS 8 0.0005
838 LEUKOPENIA 25 0.0005
839 STOMATITIS 30 0.0005
840 HEPATOCELLULAR INJURY 7 0.0005
841 FEEDING DISORDER 10 0.0005
842 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
843 BLOOD GLUCOSE ABNORMAL 9 0.0005
844 RASH MACULAR 17 0.0005
845 OROPHARYNGEAL PAIN 45 0.0005
846 INFLUENZA LIKE ILLNESS 40 0.0005
847 OSTEONECROSIS OF JAW 12 0.0005
848 PYREXIA 167 0.0005
849 RASH ERYTHEMATOUS 23 0.0005
850 AGEUSIA 12 0.0005
851 SKIN DISORDER 16 0.0005
852 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
853 THERAPEUTIC RESPONSE DECREASED 29 0.0005
854 URTICARIA 80 0.0005
855 MYALGIA 81 0.0005
856 INJECTION SITE BRUISING 38 0.0005
857 THROMBOCYTOPENIA 53 0.0005
858 CARDIOMYOPATHY 7 0.0005
859 CARDIAC FAILURE 38 0.0005
860 JOINT SWELLING 57 0.0005
861 HAEMATOCHEZIA 26 0.0005
862 MYOCARDIAL INFARCTION 82 0.0005
863 DRUG PRESCRIBING ERROR 9 0.0005
864 HAEMORRHAGE INTRACRANIAL 7 0.0005
865 INTENTIONAL OVERDOSE 30 0.0005
866 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
867 ADVERSE EVENT 43 0.0005
868 HYPOAESTHESIA ORAL 7 0.0005
869 SUICIDE ATTEMPT 28 0.0005
870 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
871 BLOOD CREATININE INCREASED 30 0.0005
872 HYPERKALAEMIA 16 0.0005
873 COLD SWEAT 8 0.0005
874 CEREBRAL INFARCTION 11 0.0004
875 NEOPLASM MALIGNANT 30 0.0004
876 PRODUCT QUALITY ISSUE 61 0.0004
877 FREQUENT BOWEL MOVEMENTS 12 0.0004
878 THROAT TIGHTNESS 12 0.0004
879 DRUG DOSE OMISSION 73 0.0004
880 PALLOR 12 0.0004
881 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
882 HOSPITALISATION 67 0.0004
883 PALPITATIONS 51 0.0004
884 ABDOMINAL PAIN LOWER 11 0.0004
885 CARDIOVASCULAR DISORDER 11 0.0004
886 DISEASE PROGRESSION 51 0.0004
887 HEPATITIS 11 0.0004
888 LIVER DISORDER 19 0.0004
889 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
890 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
891 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
892 PLATELET COUNT DECREASED 45 0.0004
893 LIP SWELLING 14 0.0004
894 BLOOD UREA INCREASED 7 0.0004
895 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
896 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
897 RHABDOMYOLYSIS 17 0.0004
898 TRANSAMINASES INCREASED 9 0.0004
899 RENAL IMPAIRMENT 34 0.0004
900 DISABILITY 8 0.0004
901 NIGHT SWEATS 13 0.0004
902 GLOSSODYNIA 9 0.0004
903 ORAL PAIN 9 0.0004
904 EOSINOPHILIA 7 0.0004
905 ERYTHEMA 82 0.0004
906 APPLICATION SITE PRURITUS 9 0.0004
907 OSTEONECROSIS 13 0.0004
908 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
909 ILL-DEFINED DISORDER 24 0.0004
910 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
911 DRY SKIN 52 0.0004
912 EMOTIONAL DISTRESS 47 0.0004
913 INFLAMMATION 20 0.0004
914 APPLICATION SITE ERYTHEMA 10 0.0004
915 JOINT STIFFNESS 10 0.0004
916 WITHDRAWAL SYNDROME 16 0.0004
917 SKIN EXFOLIATION 32 0.0004
918 LIVER FUNCTION TEST ABNORMAL 11 0.0004
919 PRODUCT PRESCRIBING ERROR 9 0.0004
920 METABOLIC ACIDOSIS 12 0.0004
921 BACTERIAL INFECTION 7 0.0004
922 DIABETIC KETOACIDOSIS 9 0.0004
923 LIVER FUNCTION TEST INCREASED 8 0.0004
924 INJECTION SITE PRURITUS 24 0.0004
925 DEATH 308 0.0004
926 HYPERGLYCAEMIA 13 0.0004
927 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
928 PSORIASIS 46 0.0004
929 ANAPHYLACTIC SHOCK 9 0.0003
930 INFUSION RELATED REACTION 23 0.0003
931 PERICARDIAL EFFUSION 8 0.0003
932 ANHEDONIA 9 0.0003
933 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
934 DRUG WITHDRAWAL SYNDROME 29 0.0003
935 PRESYNCOPE 8 0.0003
936 INCORRECT DOSE ADMINISTERED 75 0.0003
937 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 59 0.0003
938 INJECTION SITE RASH 10 0.0003
939 INJECTION SITE MASS 12 0.0003
940 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
941 APPLICATION SITE PAIN 7 0.0003
942 ANGIOEDEMA 14 0.0003
943 INTENTIONAL DOSE OMISSION 9 0.0003
944 DISCOMFORT 19 0.0003
945 INJECTION SITE PAIN 95 0.0003
946 EXPOSURE VIA SKIN CONTACT 8 0.0003
947 ACUTE MYOCARDIAL INFARCTION 9 0.0003
948 INJECTION SITE ERYTHEMA 37 0.0003
949 NO ADVERSE EVENT 54 0.0003
950 JAUNDICE 8 0.0003
951 DISEASE RECURRENCE 14 0.0003
952 LUNG NEOPLASM MALIGNANT 12 0.0003
953 COLITIS ULCERATIVE 13 0.0003
954 RHEUMATOID ARTHRITIS 33 0.0003
955 BONE DENSITY DECREASED 9 0.0003
956 DRUG-INDUCED LIVER INJURY 9 0.0003
957 SKIN BURNING SENSATION 20 0.0003
958 DRUG ABUSE 23 0.0003
959 INJECTION SITE SWELLING 21 0.0003
960 ASCITES 8 0.0003
961 INTERSTITIAL LUNG DISEASE 13 0.0003
962 PANCYTOPENIA 15 0.0003
963 DEVICE USE ERROR 9 0.0003
964 PSORIATIC ARTHROPATHY 10 0.0002
965 NEUTROPHIL COUNT DECREASED 10 0.0002
966 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
967 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
968 DEVICE LEAKAGE 10 0.0002
969 DEVICE DISLOCATION 10 0.0002
970 BREAST CANCER 21 0.0002
971 ACNE 17 0.0002
972 PRODUCT ADHESION ISSUE 8 0.0002
973 DEVICE ISSUE 20 0.0002
974 EXTRA DOSE ADMINISTERED 9 0.0002
975 NEUTROPENIA 30 0.0002
976 SKIN IRRITATION 10 0.0002
977 HEPATIC FUNCTION ABNORMAL 8 0.0002
978 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
979 PLASMA CELL MYELOMA 8 0.0002
980 FEBRILE NEUTROPENIA 13 0.0002
981 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
982 INJECTION SITE REACTION 13 0.0002
983 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
984 PRODUCT STORAGE ERROR 16 0.0002
985 PROSTATE CANCER 14 0.0002
986 ECZEMA 9 0.0002
987 ANAPHYLACTIC REACTION 9 0.0002
988 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
989 DRUG DEPENDENCE 21 0.0001
990 DEVICE DIFFICULT TO USE 8 0.0001
991 EXPOSURE DURING PREGNANCY 7 0.0001
992 DRUG DOSE OMISSION BY DEVICE 8 0.0001